Anti-β2GPI/Human Leukocyte Antigen (HLA)-DR antibodies has been reported as a new aPL test based on a novel mechanism of antigen presentation.46 The specific APS susceptible HLA-DR alleles influence the cell-surface expression of β2GPI/HLA-DR complexes. This evidence concerns the gene APOH and autoimmune polyendocrinopathy.